Mark Cuban's anti-PBM agenda gains traction with Kamala Harris

Also: How hospitals are grappling with the IV fluid shortage wrought by Hurricane Helene

October 9, 2024 Check out STAT+

Sponsored By

JONATHAN NACKSTRAND/AFP via Getty Images 2024 Nobel Prize in chemistry: Three scientists win for groundbreaking work in proteins The prize went to David Baker of the University of Washington and Demis Hassabis and John Jumper of Google DeepMind. By Andrew Joseph How hospitals are grappling with the IV fluid shortage wrought by Hurricane Helene Hospitals faced with IV fluid shortages in the wake of Hurricane Helene are giving patients Gatorade and waiting longer to replace IV bags. By Usha Lee McFarling STAT+ | Q&A: How the FDA is approaching AI in clinical trials and drug development The Food and Drug Administration's Tala Fakhouri discusses the federal agency's approach to the regulation of AI in clinical trials. By Katie Palmer Kevin Dietsch/Getty Images STAT+ | Major PBMs ask judge to remove Lina Khan from FTC's insulin-price lawsuit The legal effort from UnitedHealth, CVS, and Cigna is an escalation in the PBMs' campaign to undermine Khan and the FTC investigation. By Bob Herman STAT+ | As U.S. efforts stall, China pushes ahead with CRISPR treatments for muscular dystrophy Two Chinese biotechs are testing gene editing in boys with Duchenne muscular dystrophy, even as projects at U.S. companies like Vertex have slowed. By Jason Mast STAT+ | Eli Lilly, Insitro ink a new kind of AI drug development deal Machine-learning drug development company Insitro has inked three agreements with Eli Lilly for new medicines for metabolic diseases. By Brittany Trang BRENDAN SMIALOWSKI/AFP via Getty Images Mark Cuban is pushing his anti-PBM agenda with Kamala Harris — and it's working The billionaire co-founder of Mark Cuban Cost Plus Drugs said Tuesday that Harris "likes the idea of transparency, and she sees that as a winner." By Rachel Cohrs Zhang

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser